{name}
{subtitle}
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
city
~5 mi. (Nice, France, +176 more cities)
facility
Centre Antoine Lacassagne ( Site 2073)
condition
Endometrial Carcinoma, +1 more condition
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
city
~5 mi. (Nice, France, +150 more cities)
facility
Centre Antoine Lacassagne ( Site 0351)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +2 more types
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
city
~5 mi. (Nice, France, +201 more cities)
facility
CHU de Nice - Hôpital Archet 1 /ID# 220992
drug
azacitidine, +1 more drug
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)
city
~5 mi. (Nice, France, +127 more cities)
facility
Chu de Nice-Hopital L'Archet Ii /Id# 214056
drug
azacitidine, +2 more drugs
A Study of Oral Venetoclax Tablets and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
city
~5 mi. (Nice, France, +197 more cities)
facility
CHU de Nice - Hôpital Archet 1 /ID# 217368
biomarker
BCR-ABL1 Fusion, +47 more biomarkers
drug
azacitidine, +1 more drug
A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
city
~5 mi. (Nice, France, +156 more cities)
facility
Centre Antoine Lacassagne - Nice /ID# 234155
biomarker
IGH-CCND1 Fusion, +1 more biomarker
drug
dexamethasone, +1 more drug
drug type
chemotherapy, +1 more type
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)
city
~5 mi. (Nice, France, +105 more cities)
facility
Centre Antoine Lacassagne ( Site 0610)
biomarker
ATM Loss, +62 more biomarkers
condition
Breast Carcinoma, +2 more conditions